Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities... Show more
CME saw its Momentum Indicator move above the 0 level on September 23, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 103 similar instances where the indicator turned positive. In of the 103 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Moving Average Convergence Divergence (MACD) for CME just turned positive on September 18, 2025. Looking at past instances where CME's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CME advanced for three days, in of 332 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 69 cases where CME's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
CME moved below its 50-day moving average on October 01, 2025 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CME declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CME broke above its upper Bollinger Band on September 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CME entered a downward trend on September 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.439) is normal, around the industry mean (5.458). P/E Ratio (25.695) is within average values for comparable stocks, (29.707). Projected Growth (PEG Ratio) (5.573) is also within normal values, averaging (3.562). Dividend Yield (0.036) settles around the average of (0.024) among similar stocks. P/S Ratio (14.793) is also within normal values, averaging (8.752).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CME’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
an operator of securities and commodity exchanges
Industry FinancialPublishingServices
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GDMN | 80.85 | 0.92 | +1.15% |
WisdomTree Efcnt Gld Pls Gld Ms Stgy ETF | |||
MCSE | 14.90 | 0.08 | +0.51% |
Franklin Sustainable Intl Eq ETF | |||
IBGK | 24.12 | 0.02 | +0.07% |
iShares iBonds Dec 2054 Term Trsy ETF | |||
SCHO | 24.36 | 0.01 | +0.04% |
Schwab Short-Term US Treasury ETF™ | |||
BSJP | 23.06 | N/A | N/A |
Invesco BulletShares 2025 HY Corp Bd ETF |
A.I.dvisor indicates that over the last year, CME has been loosely correlated with CBOE. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CME jumps, then CBOE could also see price increases.
Ticker / NAME | Correlation To CME | 1D Price Change % | ||
---|---|---|---|---|
CME | 100% | -0.29% | ||
CBOE - CME | 61% Loosely correlated | -0.81% | ||
ICE - CME | 46% Loosely correlated | +1.02% | ||
TW - CME | 45% Loosely correlated | +1.84% | ||
MKTX - CME | 35% Loosely correlated | +0.54% | ||
NDAQ - CME | 24% Poorly correlated | +0.31% | ||
More |
Ticker / NAME | Correlation To CME | 1D Price Change % |
---|---|---|
CME | 100% | -0.29% |
Financial Publishing/Services industry (38 stocks) | 26% Poorly correlated | -0.09% |
Commercial Services industry (190 stocks) | 16% Poorly correlated | +0.48% |